Genetic aberrations of the K-ras proto-oncogene in bladder cancer in Kashmiri population

Urology Journal

Volumn 7, Issue 3, 2010, Pages 168-173

  Nanda, Mahoor S ^a,b   Syed Sameer, A ^b   Syeed, Nidda ^b   Shah, Zaffar A ^b   Murtaza, Imtiyaz ^a   Siddiqi, Mushtaq A ^b   Ali, Arif ^a  

^a JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Genetics; Proto oncogene protein; Ras genes; Urinary bladder neoplasm

Indexed keywords

DNA;

ARTICLE; BLADDER TUMOR; CHROMOSOME ABERRATION; COMPARATIVE STUDY; FEMALE; GENETICS; HUMAN; INDIA; MALE; METABOLISM; MIDDLE AGED; MUTATION; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PREVALENCE; TRANSITIONAL CELL CARCINOMA;

CARCINOMA, TRANSITIONAL CELL; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FEMALE; GENES, RAS; HUMANS; INDIA; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; URINARY BLADDER NEOPLASMS;

EID: 78649754716     PISSN: 17351308     EISSN: 1735546X     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-49.
2. Ferlay J, Randi G, Bosetti C, et al. Declining mortality from bladder cancer in Europe. BJU Int. 2008;101: 11-9.
3. Dhar GM, Shah GN, Naheed B, Hafiza. Epidemiological trend in the distribution of cancer in Kashmir Valley. J Epidemiol Community Health. 1993;47:290-2.
4. Varras MN, Koffa M, Koumantakis E, et al. ras gene mutations in human endometrial carcinoma. Oncology. 1996;53:505-10.
5. W atzinger F, Lion T. RAS family Atlas Genet Cytogenet Oncol Haematol. 1999;http://AtlasGeneticsOncology. org/Deep/Ras.html.
6. Capon DJ, Chen EY, Levinson AD, Seeburg PH, Goeddel DV. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue. Nature. 1983;302:33-7.
7. Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer. 2007;7:295-308.
8. Shields JM, Pruitt K, McFall A, Shaub A, Der CJ. Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol. 2000;10:147-54.
9. Ulku AS, Der CJ. Ras signaling, deregulation, of gene expression and oncogenesis. In: Frank DA, ed. In signal transduction in cancer. 1 ed. New York: Kluwer Academic Publishers; 2004:189-209.
10. Shinohara N, Koyanagi T. Ras signal transduction in carcinogenesis and progression of bladder cancer: molecular target for treatment? Urol Res. 2002;30:273-81.
11. Bos JL. ras oncogenes in human cancer: a review. Cancer Res. 1989;49:4682-9.
12. Karimianpour N, Mousavi-Shafaei P, Ziaee AA, et al. Mutations of RAS gene family in specimens of bladder cancer. Urol J. 2008;5:237-42.
13. Oxford G, Theodorescu D. The role of Ras superfamily proteins in bladder cancer progression. J Urol. 2003;170:1987-93.
14. Fitzgerald JM, Ramchurren N, Rieger K, et al. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors. J Natl Cancer Inst. 1995;87:129-33.
15. Czerniak B, Cohen GL, Etkind P, et al. Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomas. Hum Pathol. 1992;23:1199-204.
16. Jebar AH, Hurst CD, Tomlinson DC, Johnston C, Taylor CF, Knowles MA. FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene. 2005;24: 5218-25.
17. Buyru N, Tigli H, Ozcan F, Dalay N. Ras oncogene mutations in urine sediments of patients with bladder cancer. J Biochem Mol Biol. 2003;36:399-402.
18. Cattan N, Saison-Behmoaras T, Mari B, et al. Screening of human bladder carcinomas for the presence of Ha-ras codon 12 mutation. Oncol Rep. 2000;7:497-500.
19. Viola MV, Fromowitz F, Oravez S, Deb S, Schlom J. ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma. J Exp Med. 1985;161:1213-8.
20. Sameer AS, ul Rehman S, Pandith AA, et al. Molecular gate keepers succumb to gene aberrations in colorectal cancer in Kashmiri population, revealing a high incidence area. Saudi J Gastroenterol. 2009;15:244-52.
21. Levesque P, Ramchurren N, Saini K, Joyce A, Libertino J, Summerhayes IC. Screening of human bladder tumors and urine sediments for the presence of H-ras mutations. Int J Cancer. 1993;55:785-90.
22. Sameer AS, Chowdhri NA, Abdullah S, Shah ZA, Siddiqi MA. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report. Indian J Cancer. 2009;46:219-25.
23. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell. 1988;53:549-54.
24. Smit VT, Boot AJ, Smits AM, Fleuren GJ, Cornelisse CJ, Bos JL. KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res. 1988;16:7773-82.
25. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-32.
26. Olderoy G, Daehlin L, Ogreid D. Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder. Anticancer Res. 1998;18:2675-8.
27. Uchida T, Wada C, Ishida H, et al. Infrequent involvement of mutations on neurofibromatosis type 1, H-ras, K-ras and N-ras in urothelial tumors. Urol Int. 1995;55:63-7.
28. Zhang ZT, Pak J, Huang HY, et al. Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation. Oncogene. 2001;20:1973-80.
29. Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer. 2001;1:222-31.
30. Campbell PM, Der CJ. Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol. 2004;14:105-14.
31. Giehl K. Oncogenic Ras in tumour progression and metastasis. Biol Chem. 2005;386:193-205.
32. Pozzatti R, Muschel R, Williams J, et al. Primary rat embryo cells transformed by one or two oncogenes show different metastatic potentials. Science. 1986;232:223-7.
33. Al-Mulla F, MacKenzie EM. Differences in in vitro invasive capacity induced by differences in Ki-Ras protein mutations. J Pathol. 2001;195:549-56.
34. Yan Z, Chen M, Perucho M, Friedman E. Oncogenic Ki-ras but not oncogenic Ha-ras blocks integrin beta1-chain maturation in colon epithelial cells. J Biol Chem. 1997;272:30928-36.
35. Dolin PJ. An epidemiological review of tobacco use and bladder cancer. J Smoking Related Dis. 1991;2:129-43.
36. Seeburg PH, Colby WW, Capon DJ, Goeddel DV, Levinson AD. Biological properties of human c-Ha-ras1 genes mutated at codon 12. Nature. 1984;312:71-5.
37. Stenson PD, Ball EV, Mort M, et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat. 2003;21:577-81.
38. Lijinsky W. N-Nitroso compounds in the diet. Mutat Res. 1999;443:129-38.